CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)
Authors
A Guidetti
AF List
+34 more
AR Jazirehi
BC Cheson
Brad S Kahl
CR Weinstein-Oppenheimer
D Gratzinger
Daniel R Greenwald
David King
ES Wang
G Bollag
G Procopio
Hailun Li
J Downward
Jill Kolesar
K Ganjoo
LM Shlapatska
M Kobzdej
PH Wiernik
R Buckstein
R Dalla-Favera
R Simon
Randy D Gascoyne
RH Advani
Ronald S Go
Sandra Horning
Selina M Luger
SM Wilhelm
T Hunter
T Ogasawara
T Philip
Taral Patel
TB Lowinger
TE Hutson
W Kalas
X Zhang
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2F1756-8722-6...
Last time updated on 05/06/2019